These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 2898027

  • 1. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III.
    JAMA; 1988 Jul 15; 260(3):359-66. PubMed ID: 2898027
    [Abstract] [Full Text] [Related]

  • 2. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E, Kreisberg R, Miller V, Mantell G, Washington L, Shapiro DR.
    Arch Intern Med; 1990 Feb 15; 150(2):341-5. PubMed ID: 2405804
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun 14; 153(11):1321-9. PubMed ID: 8507122
    [Abstract] [Full Text] [Related]

  • 4. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW, Huff M, Oskalns R, Rudas L, Kostuk WJ.
    J Heart Lung Transplant; 1995 Jun 14; 14(4):613-22. PubMed ID: 7578166
    [Abstract] [Full Text] [Related]

  • 5. Comparison between lovastatin and cholestyramine in the treatment of moderate to severe primary hypercholesterolaemia.
    Ebeling T, Turtola H, Voutilainen E, Uusitupa M, Pyörälä K, Reijonen T.
    Ann Med; 1992 Apr 14; 24(2):121-7. PubMed ID: 1610539
    [Abstract] [Full Text] [Related]

  • 6. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E, Aranda JL, Nogués X, del Palacio A, Rubiés-Prat J.
    Med Clin (Barc); 1996 May 25; 106(20):776-9. PubMed ID: 8801396
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
    Denke MA, Grundy SM.
    Arch Intern Med; 1995 Feb 27; 155(4):393-9. PubMed ID: 7848022
    [Abstract] [Full Text] [Related]

  • 8. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia.
    Leren TP, Hjermann I, Berg K, Leren P, Foss OP, Viksmoen L.
    Atherosclerosis; 1988 Oct 27; 73(2-3):135-41. PubMed ID: 3056429
    [Abstract] [Full Text] [Related]

  • 9. [Lovastatin in primary hypercholesterolemia. A Norwegian multicenter study].
    Ose L.
    Tidsskr Nor Laegeforen; 1992 Nov 30; 112(29):3665-9. PubMed ID: 1471127
    [Abstract] [Full Text] [Related]

  • 10. Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia.
    Mölgaard J, von Schenck H, Olsson AG.
    Eur J Clin Pharmacol; 1989 Nov 30; 36(5):455-60. PubMed ID: 2502417
    [Abstract] [Full Text] [Related]

  • 11. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
    Bard JM, Parra HJ, Douste-Blazy P, Fruchart JC.
    Metabolism; 1990 Mar 30; 39(3):269-73. PubMed ID: 2106607
    [Abstract] [Full Text] [Related]

  • 12. Comparative study of a microporous cholestyramine analogue (filicol) and gemfibrozil for treatment of severe primary hypercholesterolemia. Short- and long-term results.
    Ros E, Zambón D, Bertomeu A, Cusó E, Sanllehy C, Casals E.
    Arch Intern Med; 1991 Feb 30; 151(2):301-5. PubMed ID: 1992957
    [Abstract] [Full Text] [Related]

  • 13. A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia. The Lovastatin Study Group IV.
    Am J Cardiol; 1990 Sep 18; 66(8):22B-30B. PubMed ID: 2206033
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy with lovastatin and guar gum versus lovastatin and cholestyramine in treatment of hypercholesterolemia.
    Uusitupa M, Ebeling T, Happonen P, Voutilainen E, Turtola H, Parviainen M, Pyörälä K.
    J Cardiovasc Pharmacol; 1991 Oct 18; 18(4):496-503. PubMed ID: 1724525
    [Abstract] [Full Text] [Related]

  • 15. Comparison between low-dose simvastatin and cholestyramine in moderately severe hypercholesterolemia.
    Deslypere JP.
    Acta Cardiol; 1989 Oct 18; 44(5):379-88. PubMed ID: 2690545
    [Abstract] [Full Text] [Related]

  • 16. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
    O'Brien RC, Simons LA, Clifton P, Cooper ME, Jennings GL, Jerums G, Nestel PJ, Sullivan D.
    Med J Aust; 1990 May 07; 152(9):480-3. PubMed ID: 2199801
    [Abstract] [Full Text] [Related]

  • 17. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
    März W, Grützmacher P, Paul D, Siekmeier R, Schoeppe W, Gross W.
    Int J Clin Pharmacol Ther; 1994 Feb 07; 32(2):92-7. PubMed ID: 8004365
    [Abstract] [Full Text] [Related]

  • 18. [Cholestyramine in the treatment of hypercholesterolemia. Our experience in 11 cases].
    Maíz A, Arteaga A, Villanueva CL, Velasco N, Acosta AM.
    Rev Med Chil; 1990 Sep 07; 118(9):1009-13. PubMed ID: 2152729
    [Abstract] [Full Text] [Related]

  • 19. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.
    Pappu AS, Illingworth DR.
    J Lab Clin Med; 1989 Nov 07; 114(5):554-62. PubMed ID: 2809398
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.